|
|
Article: QUARK PHARMA TO PRESENT DATA ON ITS SIRNA THERAPEUTIC PROGRAMS.
- Article from:
- AsiaPulse News
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 Asia Pulse Pty Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
(Full text of statement. Contact details below.)
MEDIA RELEASE PR36853
Quark Pharmaceuticals to Present Data on its siRNA Therapeutic Programs in Kidney and Lung Diseases
FREMONT, Calif., Nov. 2 /PRNewswire-AsiaNet/ --
Quark Pharmaceuticals, Inc., a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel RNA interference (RNAi)-based therapeutics, today announced that James D. Thompson, Ph.D., Vice President, Pharmaceutical Development, will present a case history of QPI-1002, the first systemically administered synthetic siRNA, at the Joint Symposium of the 5th Annual Meeting of ...
Related newspaper, magazine, and journal articles:
|
|
Article: Quark Pharmaceuticals Presents at Asia TIDES ...
PR Newswire;
March 9, 2009 ;
700+ words
... ... Calif., March 9 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a development-stage pharmaceutical ... its name to Sirna Therapeutics. About Quark Pharmaceuticals, Inc. Quark Pharmaceuticals, Inc. is a development-stage pharmaceutical ...
|
|